JP7863051B2 - 新規脂質及びそれらのナノ粒子組成物 - Google Patents
新規脂質及びそれらのナノ粒子組成物Info
- Publication number
- JP7863051B2 JP7863051B2 JP2022570302A JP2022570302A JP7863051B2 JP 7863051 B2 JP7863051 B2 JP 7863051B2 JP 2022570302 A JP2022570302 A JP 2022570302A JP 2022570302 A JP2022570302 A JP 2022570302A JP 7863051 B2 JP7863051 B2 JP 7863051B2
- Authority
- JP
- Japan
- Prior art keywords
- lipid
- approximately
- lipids
- cedna
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
- A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063026479P | 2020-05-18 | 2020-05-18 | |
| US63/026,479 | 2020-05-18 | ||
| PCT/US2021/032676 WO2021236479A2 (en) | 2020-05-18 | 2021-05-17 | Novel lipids and nanoparticle compositions thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023527747A JP2023527747A (ja) | 2023-06-30 |
| JP2023527747A5 JP2023527747A5 (cg-RX-API-DMAC7.html) | 2024-05-24 |
| JP7863051B2 true JP7863051B2 (ja) | 2026-05-20 |
Family
ID=78707483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022570302A Active JP7863051B2 (ja) | 2020-05-18 | 2021-05-17 | 新規脂質及びそれらのナノ粒子組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230181764A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4153144A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7863051B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN115968280A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021274481A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3175957A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL298241A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022014484A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021236479A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3864163T3 (da) | 2018-10-09 | 2024-05-06 | Univ British Columbia | Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed |
| AU2021307952A1 (en) * | 2020-07-17 | 2023-03-02 | Generation Bio Co. | Methods for encapsulating polynucleotides into reduced sizes of Lipid nanoparticles and novel formulation thereof |
| CN114716355B (zh) * | 2022-04-02 | 2023-09-05 | 华南理工大学 | 一种脂质化合物、包含其的组合物及应用 |
| CN121532216A (zh) * | 2023-04-18 | 2026-02-13 | 赛仁生物技术公司 | 腺相关病毒载体组合物和使用方法 |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| CN120330264A (zh) * | 2024-01-19 | 2025-07-18 | 晟迪生物医药(苏州)有限公司 | 基于空白脂质纳米颗粒的转染试剂、其制备方法和应用 |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013073480A1 (ja) | 2011-11-18 | 2013-05-23 | 日油株式会社 | 細胞内動態を改善したカチオン性脂質 |
| WO2016121942A1 (ja) | 2015-01-30 | 2016-08-04 | 日油株式会社 | カチオン性脂質 |
| WO2017061150A1 (ja) | 2015-10-08 | 2017-04-13 | 日油株式会社 | O/w型エマルション |
| WO2019051255A1 (en) | 2017-09-08 | 2019-03-14 | Generation Bio Co. | CLOSED-ENDED DNA (CEDNA) MODIFIED |
| WO2019188867A1 (ja) | 2018-03-27 | 2019-10-03 | 日油株式会社 | 細胞内動態を改善した新規カチオン性脂質 |
| JP2023507465A (ja) | 2019-12-20 | 2023-02-22 | キュアバック エスイー | 核酸を送達するための脂質ナノ粒子 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0610479D0 (en) * | 2006-05-26 | 2006-07-05 | Ge Healthcare Bio Sciences Ab | A method for generating metal chelating affinity ligands |
| WO2018237369A2 (en) * | 2017-06-23 | 2018-12-27 | Vical Incorporated | Lipid nanoparticle (lnp)-mediated delivery of a crispr-expressing plasmid dna for treating chronic hepatitis b virus infection |
| CN114929205B (zh) * | 2019-09-06 | 2024-09-03 | 世代生物公司 | 包括末端封闭式dna和可切割脂质的脂质纳米颗粒组合物及其使用方法 |
| WO2021060440A1 (ja) * | 2019-09-26 | 2021-04-01 | 日油株式会社 | 脂質ナノ粒子の凍結乾燥組成物 |
| AU2020385378A1 (en) * | 2019-11-22 | 2022-04-07 | Generation Bio Co. | Ionizable lipids and nanoparticle compositions thereof |
-
2021
- 2021-05-17 CN CN202180035954.4A patent/CN115968280A/zh active Pending
- 2021-05-17 CA CA3175957A patent/CA3175957A1/en active Pending
- 2021-05-17 EP EP21808224.6A patent/EP4153144A4/en active Pending
- 2021-05-17 MX MX2022014484A patent/MX2022014484A/es unknown
- 2021-05-17 JP JP2022570302A patent/JP7863051B2/ja active Active
- 2021-05-17 WO PCT/US2021/032676 patent/WO2021236479A2/en not_active Ceased
- 2021-05-17 AU AU2021274481A patent/AU2021274481A1/en active Pending
- 2021-05-17 IL IL298241A patent/IL298241A/en unknown
- 2021-05-17 US US17/925,404 patent/US20230181764A1/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013073480A1 (ja) | 2011-11-18 | 2013-05-23 | 日油株式会社 | 細胞内動態を改善したカチオン性脂質 |
| WO2016121942A1 (ja) | 2015-01-30 | 2016-08-04 | 日油株式会社 | カチオン性脂質 |
| WO2017061150A1 (ja) | 2015-10-08 | 2017-04-13 | 日油株式会社 | O/w型エマルション |
| WO2019051255A1 (en) | 2017-09-08 | 2019-03-14 | Generation Bio Co. | CLOSED-ENDED DNA (CEDNA) MODIFIED |
| WO2019188867A1 (ja) | 2018-03-27 | 2019-10-03 | 日油株式会社 | 細胞内動態を改善した新規カチオン性脂質 |
| JP2023507465A (ja) | 2019-12-20 | 2023-02-22 | キュアバック エスイー | 核酸を送達するための脂質ナノ粒子 |
Non-Patent Citations (7)
| Title |
|---|
| AKITA, Hidetaka et al.,"A Neutral Envelope‐Type Nanoparticle Containing pH‐Responsive and SS‐Cleavable Lipid‐Like Material as a Carrier for Plasmid DNA",Advanced Healthcare Materials,2013年,Vol. 2,No. 8,p. 1120-1125,DOI: 10.1002/adhm.201200431 |
| AKITA, Hidetaka et al.,"Molecular Tuning of a Vitamin E-Scaffold pH-Sensitive and Reductive Cleavable Lipid-like Material for Accelerated in Vivo Hepatic siRNA Delivery",ACS Biomaterials Science & Engineering,2015年,Vol. 1,No. 9,p. 834-844,DOI: 10.1021/acsbiomaterials.5b00203 |
| JAIN, Priyesh et al.,"Zwitterionic Hydrogels Based on a Degradable Disulfide Carboxybetaine Cross-Linker",2019年,Vol. 35、No. 5,Langmuir,p. 1864-1871,DOI: http://dx.doi.org/10.1021/acs.langmuir.8b02100 |
| TANAKA, Hiroki et al.,"In Vivo Introduction of mRNA Encapsulated in Lipid Nanoparticles to Brain Neuronal Cells and Astrocytes via Intracerebroventricular Administration",Molecular Pharmaceutics,2018年,Vol. 15、No. 5,p. 2060-2067,DOI: http://dx.doi.org/10.1021/acs.molpharmaceut.7b01084 |
| TANAKA, Hiroki et al.,"Neutral biodegradable lipid-envelope-type nanoparticle using vitamin A-Scaffold for nuclear targeting of plasmid DNA",Biomaterials,2014年,Vol. 35、No. 5,p. 1755-1761,DOI: http://dx.doi.org/10.1016/j.biomaterials.2013.11.016 |
| TANAKA, Hiroki et al.,"Temperature and pH sensitivity of a stabilized self-nanoemulsion formed using an ionizable lipid-like material via an oil-to-surfactant transition",Colloids and Surfaces B: Biointerfaces,2017年,Vol. 151,p. 95-101,DOI: http://dx.doi.org/10.1016/j.colsurfb.2016.11.020 |
| TOGASHI, Ryohei et al.,"A hepatic pDNA delivery system based on an intracellular environment sensitive vitamin E-scaffold lipid-like material with the aid of an anti-inflammatory drug",Journal of Controlled Release,2018年,Vol. 279,p. 262-270,DOI: 10.1016/j.jconrel.2018.04.022 |
Also Published As
| Publication number | Publication date |
|---|---|
| IL298241A (en) | 2023-01-01 |
| WO2021236479A3 (en) | 2021-12-23 |
| WO2021236479A8 (en) | 2022-02-24 |
| EP4153144A4 (en) | 2024-07-03 |
| MX2022014484A (es) | 2022-12-13 |
| CA3175957A1 (en) | 2021-11-25 |
| CN115968280A (zh) | 2023-04-14 |
| JP2023527747A (ja) | 2023-06-30 |
| EP4153144A2 (en) | 2023-03-29 |
| US20230181764A1 (en) | 2023-06-15 |
| AU2021274481A1 (en) | 2022-11-03 |
| WO2021236479A2 (en) | 2021-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7746280B2 (ja) | 新規脂質及びそれらのナノ粒子組成物 | |
| KR102958677B1 (ko) | 이온화 가능한 지질 및 이의 나노입자 조성물 | |
| JP2026074198A (ja) | ポリヌクレオチドを縮小サイズの脂質ナノ粒子に封入する方法及びその新規製剤 | |
| US20240293574A1 (en) | Cationic lipids and compositions thereof | |
| KR20230172570A (ko) | 양이온성 지질 및 이의 조성물 | |
| US20230181764A1 (en) | Novel lipids and nanoparticle compositions thereof | |
| AU2022311904A1 (en) | Single chain variable fragment (scfv) modified lipid nanoparticle compositions and uses thereof | |
| CN117545469A (zh) | 阳离子脂质及其组合物 | |
| RU2836646C1 (ru) | Ионизируемые липиды и их композиции в форме наночастиц |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240516 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240516 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250415 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250417 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250714 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250723 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251017 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260119 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260415 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260508 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7863051 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |